Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Yitai Pharmaceutical is a leading Chinese pharmaceutical manufacturer primarily focused on the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Established in 1998 and based in Tianmen, Hubei Province, the company has grown into one of the world's largest suppliers of caffeine, theophylline, and aminophylline. In addition to its core xanthine derivatives, the company produces analgesics such as paracetamol and various other small molecule drugs. Hubei Yitai Pharmaceutical operates large-scale manufacturing facilities that comply with international GMP standards, serving both domestic and global markets. The company is recognized for its high-volume production capabilities and significant export business to Europe, the Americas, and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Yitai Pharmaceutical.